DapKid: Effects of dapagliflozin treatment on urinary proteomic patterns in patients with Type 2 diabetes
The aim of this study is to investigate whether the treatment with dapagliflozin 10 mg x1 daily can change the proteomic pattern in a way which indicates a reduced risk of diabetic kidney disease.
REMOVAL: REducing with MetfOrmin Vascular Adverse Lesions in type 1 diabetes
ROTATE: Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetes.